Ainos, Inc. (AIMD)

Market Cap	16.70M
Revenue (ttm)	110,870
Net Income (ttm)	-15.72M
Shares Out	4.76M
EPS (ttm)	-5.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,551
Open	3.390
Previous Close	3.450
Day's Range	3.390 - 3.600
52-Week Range	2.000 - 5.000
Beta	2.27
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2025

About AIMD

Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2024, Ainos's revenue was $20,729, a decrease of -83.02% compared to the previous year's $122,112. Losses were -$14.86 million, 7.93% more than in 2023.